Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Novartis AG

14 instances of misconduct since 1995 | $1,261.2M in penalties

Headquartered in Basel, Switzerland, Novartis is a multinational pharmaceutical company created in 1996 from the merger of Swiss companies Ciba-Geigy and Sandoz Laboratories. Its main business areas include pharmaceuticals, diagnostics and vaccines, and animal health. Novartis employs approximately 100,000 people in 140 countries.

Correspondence Date
Letter to Novartis 4/29/2010
FY Rank Contract Awards
2015 N/A $34.8M
2014 N/A $33.8M
2013 N/A $109.1M
2012 N/A $66.4M
2011 N/A $59.3M

14 Instances of Misconduct since 1995

4 additional instances of misconduct pending resolution.

Date Instance Penalty
Total  
8/8/2016 Korea Kickback Prosecutions
Novartis AG
Pending
5/31/2016 Zofran Products Liability Litigation
GlaxoSmithKline, Novartis AG
Pending
3/23/2016 Chinese Subsidiary Pay-To-Prescribe
Novartis AG
$25,050,104
6/10/2014 Guo v. Novartis (Whistleblower Retaliation)
Novartis AG
Pending
4/26/2013 U.S. v. Novartis (Speaker Program False Claims)
Novartis AG
Pending
10/30/2012 Galmines v. Novartis Pharmaceutical Corp. (Elidel False Claims)
Novartis AG
$54,900,000
1/25/2012 Nationwide Wage and Hour Class Action Lawsuit
Novartis AG
$99,170,000
11/14/2011 U.S. ex rel. Kester, et al. v. Novartis et al. (Kickbacks, False Claims)
AmerisourceBergen, Novartis AG
$390,000,000
9/14/2011 Pharmaceutical Industry Average Wholesale Price Litigation
Novartis AG
$0
10/6/2010 Hawaii Average Wholesale Price Litigation
Novartis AG
$10,000,000
9/30/2010 Off-Label Promotion of Trileptal (Civil Litigation)
Novartis AG
$237,500,000
5/4/2010 False Claims Involving TOBI Cystic Fibrosis Drug
Novartis AG
$72,500,000
4/21/2010 FDA Review of Gleevec Promotional Material
Novartis AG
$0
3/8/2010 Breeden v. Novartis (FMLA Retaliation)
Novartis AG
$579,338
2/22/2010 Conrad v. Eon Labs (False Claims)
Novartis AG
$3,500,000
1/26/2010 Off-Label Promotion of Trileptal (Criminal Prosecution)
Novartis AG
$185,000,000
11/19/2004 Velez v. Novartis Corp. (Gender Discrimination)
Novartis AG
$175,000,000
3/11/1999 Overcharging Dept. of Veterans Affairs
Novartis AG
$8,000,000

Federal Contractor Misconduct Database

Contractor Contact Information

Contractor Links